Problems in the Estimation of the Key Parameters using MLE in Lung Cancer Screening.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Inference of Onset Age of Preclinical State and Sojourn Time for Breast Cancer.Medical research archives · 2022
   Article
2. Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.Statistics and its interface · 2022
   Article
3. Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer.Medical research archives · 2021
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.